Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2020-04-21 Regulatory Filings
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Independent Test Results For The Wondfo SARS-CoV-2 Test 2 pages 72.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement reporting independent test results for a COVID-19 diagnostic test (Wondfo SARS-CoV-2 test). It provides detailed study results, validation data, and context about the test's utility and regulatory approvals. There is no indication that this is a financial report, earnings release, management discussion, or regulatory filing related to financials. It is a product test result announcement related to medical diagnostics, not fitting into financial report categories. The document is not a report publication announcement or a certification. It is a general regulatory announcement about product test results and validation, which fits best under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific financial or corporate filing categories.
2020-04-21 English
Notice of General Meeting/Proxy Form 15 pages 1.7MB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of General Meeting and Explanatory Statement for a shareholder meeting of Cellmid Limited scheduled for May 2020. It includes details about the meeting venue, voting procedures, proxy forms, and resolutions to be voted on, such as approval of share issues to directors and broker options. The content is typical of materials sent to shareholders to inform them about the meeting agenda and to solicit votes. It is not a report of financial results, audit, or management discussion, nor is it a transcript or announcement of voting results. It is a proxy solicitation and information statement designed to provide shareholders with information and request their votes for the meeting resolutions.
2020-04-20 English
Security Purchase Plan 6 pages 218.5KB
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement and offer of a Share Purchase Plan (SPP) by Cellmid Limited, including terms and conditions, subscription details, eligibility criteria, pricing, and important dates. It discusses a capital raising activity through issuing new shares to existing shareholders at a discounted price. There is no financial statement or earnings data presented, nor is it a report or transcript. The content focuses on fundraising and capital structure changes. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the capital raising plan, not just a brief announcement or regulatory filing, so it is not RNS or RPA. Confidence is high due to the clear focus on share issuance and capital raising terms.
2020-04-16 English
Appendix 2A and Cleansing Notice 16 pages 297.9KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. The document is a regulatory form used to notify the exchange about new securities issuance and quotation requests. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement but a formal regulatory filing required by the exchange. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-04-13 English
Pause in Trading 1 page 109.8KB
Regulatory Filings Classification · 95% confidence The document is a short market release announcing a temporary pause in trading of the company's securities. It does not contain financial data, report content, or detailed information about management, capital, or legal matters. It is a regulatory announcement related to trading status, which fits best under Regulatory Filings (RNS) as a general compliance and market announcement. The document length is very short (332 characters), and it is clearly an announcement rather than a report or detailed filing.
2020-04-13 English
Cellmid's Shipment of SARS-CoV-2 Tests Received 1 p
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 14 April 2020 regarding Cellmid Limited's shipment of SARS-CoV-2 rapid diagnostic tests. It provides information about the shipment arrival, product details, regulatory certifications, and company background. The document is short (2889 characters) and serves as a news update or announcement rather than a detailed financial report or regulatory filing. There is no financial data, no mention of voting results, no management changes, no earnings data, and no detailed investor presentation. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best as a general regulatory announcement about company operations and product shipment. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-04-13 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.